| Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda (NCT07548021) | Medicines for Malaria Venture | 2026-09-01 |
| Evaluation of Safety, Pharmacokinetics, Distribution，Radiation Safety and Sensitivity/Specificity of PET/CT Imaging With 68Ga-NYM096 in Participants With IRM (NCT07768306) | Norroy Bioscience Co., LTD | 2026-09-01 |
| Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations (NCT07275359) | Duke University | 2026-09-01 |
| Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study (NCT07360301) | University of Wisconsin, Madison | 2026-09-01 |
| Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy (NCT07769671) | The First People's Hospital of Changzhou | 2026-09-01 |
| FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia (NCT07645469) | Fred Hutchinson Cancer Center | 2026-09-01 |
| Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use (NCT07218549) | Christopher D. Verrico | 2026-09-01 |
| Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing (NCT07743086) | Barbara Ann Karmanos Cancer Institute | 2026-09-01 |
| Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder (NCT07593222) | Mclean Hospital | 2026-09-01 |
| Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain (NCT07728695) | Staci Gruber, Ph.D. | 2026-09-01 |
| Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma (NCT07759102) | University of California, Davis | 2026-09-01 |
| Coordinated Reset Deep Brain Stimulation for Parkinson's Disease (NCT07340073) | University of Minnesota | 2026-09-01 |
| HiCM-188 Cell Therapy in Adults With Advanced Heart Failure Undergoing Heart Bypass Surgery (NCT07646210) | HELP Therapeutics Co., Ltd. | 2026-09-01 |
| A Cognitive Mobile Intervention for Motivation in Psychotic Disorders (NCT07674914) | University of Alabama at Birmingham | 2026-09-01 |
| SKB565 for Injection in Advanced Solid Tumors (NCT07545265) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-09-01 |
| Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma (NCT07532525) | University of Michigan Rogel Cancer Center | 2026-09-01 |
| Safety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC) (NCT07555587) | NRT MedTech Australia Pty Ltd | 2026-09-01 |
| Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum (NCT07509008) | M.D. Anderson Cancer Center | 2026-09-01 |
| The Optimal One-Month Dosing of Lemborexant for Moderate Obstructive Sleep Apnea (OSA) Patients With Low Arousal Threshold (NCT07683442) | Chulalongkorn University | 2026-09-01 |
| A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia (NCT07313852) | Memorial Sloan Kettering Cancer Center | 2026-09-01 |
| Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert (NCT06668896) | Daré Bioscience, Inc. | 2026-09-01 |
| Venetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid Leukemia (NCT07726576) | University Hospital, Bordeaux | 2026-09-01 |
| A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity (NCT07754474) | Boehringer Ingelheim | 2026-09-01 |
| Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma (NCT07611149) | Kure Cells, INC | 2026-09-01 |
| A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate (NCT06941480) | Memorial Sloan Kettering Cancer Center | 2026-09-01 |
| Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies (NCT07335328) | Medical College of Wisconsin | 2026-09-01 |
| Phase 2 Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC (NCT07540832) | Zhejiang Haichang Biotech Co., Ltd. | 2026-09-01 |
| A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma (NCT07650266) | Memorial Sloan Kettering Cancer Center | 2026-09-01 |
| Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT07665515) | Epitopea Ltd | 2026-09-01 |
| Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy (NCT07762716) | BreakBio Corp | 2026-09-01 |
| EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer (NCT07698613) | Brown University | 2026-09-01 |
| Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD) (NCT07681778) | Opus Genetics, Inc | 2026-09-01 |
| DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer (NCT07705919) | Ohio State University Comprehensive Cancer Center | 2026-09-01 |
| Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma (NCT07555561) | Beijing Boren Hospital | 2026-09-01 |
| A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients (NCT07398404) | Medical University of South Carolina | 2026-09-01 |
| A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019) (NCT07600775) | Merck Sharp & Dohme LLC | 2026-09-01 |
| A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients (NCT07573332) | University of Texas Southwestern Medical Center | 2026-09-01 |
| The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy (NCT06425419) | Massachusetts Eye and Ear Infirmary | 2026-09-01 |
| Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases (NCT07544225) | Gustave Roussy, Cancer Campus, Grand Paris | 2026-09-01 |
| Phase I/II Clinical Trials of SHR-8203 Injection in Participants With Advanced Solid Tumors (NCT07769242) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2026-09-01 |
| Microbiota Transplant With Antibiotic Preconditioning and Fiber Supplementation in PAH. (NCT07751120) | University of Minnesota | 2026-09-01 |
| Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency Syndrome (NCT07540351) | Beijing Daxing District Hospital of Integrated Chinese and Western Medicine | 2026-09-01 |
| R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS) (NCT07646028) | Rise Therapeutics LLC | 2026-09-01 |
| First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer (NCT07756281) | Synnovation Therapeutics, Inc. | 2026-09-01 |
| OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis (NCT07221799) | University of Maryland, Baltimore | 2026-09-01 |
| Preliminary Clinical Feasibility Study of a Medical Device Enabling Brain Access Using Microbubble-Enhanced Sonication (NCT07754006) | Gustave Roussy, Cancer Campus, Grand Paris | 2026-09-01 |
| Pharmacokinetics, Pharmacodynamics, and Safety of NANOKINE Compared With Eprex 4000 U in Healthy Volunteers (NCT06919861) | Nanogen Pharmaceutical Biotechnology Joint Stock Company | 2026-09-01 |
| Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy (NCT07642635) | Vanderbilt University Medical Center | 2026-09-01 |
| Multiple Ascending Dose Study of DW4421 (NCT07691242) | Daewon Pharmaceutical Co., Ltd. | 2026-09-01 |
| Cannabis Gummy for the Improvement of Sleep and Quality of Life in Patients With Cancer, Pillow Trial (NCT07658677) | Theodore Brasky PhD | 2026-09-01 |
| Novel Irrigation Solution for Colonoscopy Visualization Pilot (NCT07769905) | NYU Langone Health | 2026-09-01 |
| Pacritinib With Aza for Upfront Myelodysplastic Syndrome (NCT07387354) | Thomas Jefferson University | 2026-09-01 |
| A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A (NCT07226206) | Hoffmann-La Roche | 2026-09-01 |
| Phase 1 Study of Oral MG001 (NCT07204171) | National Institute on Drug Abuse (NIDA) | 2026-09-01 |
| TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM) (NCT07720843) | Montefiore Medical Center | 2026-09-01 |
| Impact of Sweeteners on the Addictive Threshold of Nicotine (NCT07771725) | Yale University | 2026-09-01 |
| Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients (NCT07224087) | Medical University of South Carolina | 2026-09-01 |
| The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function (NCT07079852) | Manoj Doss | 2026-09-01 |
| Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial (NCT07579195) | University of Washington | 2026-09-01 |
| Little Lungs Study (NCT06855043) | University of Wisconsin, Madison | 2026-09-01 |
| Evaluation of the Safety and Efficacy of LB-DTK-BKV in Patients With BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation (NCT07638332) | LucasBio | 2026-09-01 |
| Terazosin And Metabolic Engagement in Parkinson's Disease (NCT07288450) | Nandakumar Narayanan | 2026-09-01 |
| A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers (NCT07545122) | Context Therapeutics Inc. | 2026-09-01 |
| Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy (NCT07018739) | Mahidol University | 2026-09-01 |
| IL6-receptor Inhibitor Iwith Belumosudil for the Treatment of Belumosudil-refractory cGVHD (NCT07484113) | Stanford University | 2026-09-01 |
| BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies (NCT07679919) | Luminary Therapeutics | 2026-09-01 |
| Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML (NCT07723703) | Amphista Therapeutics Ltd | 2026-09-01 |
| Study Evaluating a Gene Therapy for IPEX Syndrome Through the Expression of FOXP3 on Deficient T Cells to Produce Tregs-like. (NCT07697118) | Assistance Publique - Hôpitaux de Paris | 2026-09-01 |
| The REValve Clinical Trial an Evaluation Of the ReValve Palmetto Valve for the Replacement of the Native Mitral VaLVE (NCT07450911) | ReValve Solutions Inc. | 2026-09-01 |
| First in Human Study of BETA-TT8 in wetAge-related Macular Degeneration (wetAMD) (NCT07766473) | Filamon LTD | 2026-09-01 |
| A Study of ATG-201 in Adult Participants With Autoimmune Diseases (NCT07732309) | Antengene Biologics Limited | 2026-09-01 |
| DK222 Study at Hopkins (NCT07140315) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-09-01 |
| Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients (NCT07317154) | Mayo Clinic | 2026-09-01 |
| Pregnenolone for Cannabis Use Disorder and Depression (NCT07685964) | University of Texas Southwestern Medical Center | 2026-09-01 |
| Neural Effects of Intravenous N,N-dimethyltryptamine (DMT) (NCT07693257) | Jon Dean | 2026-09-01 |
| A First-in-human (FIH), Open-Label, Dose Escalation and Expansion Cohorts Study of MC002 (NCT07726212) | Hangzhou MacroLink Biopharmaceutical LLC | 2026-09-01 |
| Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma (NCT07686744) | Jian Lin | 2026-09-01 |
| GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT) (NCT07513194) | Baylor College of Medicine | 2026-09-01 |
| Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congenital Heart Disease Undergoing Surgical Repair (NCT07486167) | Charite University, Berlin, Germany | 2026-09-01 |
| Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma (NCT07676877) | Nathan Denlinger | 2026-09-01 |
| Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML. (NCT07757672) | Institute of Hematology & Blood Diseases Hospital, China | 2026-09-01 |
| A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection (NCT07051187) | Jiyan Liu | 2026-09-01 |
| A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma (NCT07422896) | Catalina Lee Chang | 2026-09-01 |
| A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours) (NCT07744152) | Boehringer Ingelheim | 2026-08-31 |
| Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema (NCT06881888) | University of Alabama at Birmingham | 2026-08-31 |
| Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs (NCT07578467) | Abramson Cancer Center at Penn Medicine | 2026-08-31 |
| Phase Ia Trial of HHK001 Compared With Enantone in Patients With Endometriosis (NCT07755956) | Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd. | 2026-08-31 |
| A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage (NCT07770685) | Astellas Pharma Global Development, Inc. | 2026-08-31 |
| A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma. (NCT06970496) | Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. | 2026-08-31 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PTT-121 (NCT07768176) | Pyrotech Therapeutics, Inc. | 2026-08-31 |
| ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk MDS (NCT07617363) | Washington University School of Medicine | 2026-08-31 |
| The Effects of Psilocybin on Social Connectedness (NCT07693153) | Yale University | 2026-08-31 |
| PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma (NCT06639607) | Washington University School of Medicine | 2026-08-31 |
| A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma (NCT07567469) | Regeneron Pharmaceuticals | 2026-08-31 |
| Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma (NCT07414979) | M.D. Anderson Cancer Center | 2026-08-31 |
| Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) (NCT07200089) | Washington University School of Medicine | 2026-08-31 |
| Shortened LSD Intervention for Major Depressive Disorder (NCT07503002) | Johns Hopkins University | 2026-08-31 |
| Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye Disease (NCT07762105) | Banu Aji Dibyasakti | 2026-08-30 |
| ECP-DL Cell Infusion for Induction in Living Donor Kidney (LDK) Transplants (NCT07083830) | Northwestern University | 2026-08-30 |
| A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma (NCT07758491) | FutureGen Biopharmaceutical (Beijing) Co., Ltd | 2026-08-30 |